Brought to you by 
Sequenom acquires patents from Helicos BioSciences
04 Jan 2022
Executive Summary
Genetic test developer Sequenom Inc. has purchased Helicos BioSciences Corp.’s (genetic analysis systems) US patent applications 12/709,057 and 12/727,824 (“Methods for Detecting Fetal Nucleic Acids” and “Diagnosing Fetal Abnormalities”, respectively).
Deal Industry
- Biotechnology
- In Vitro Diagnostics
-
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
Deal Status
- Final
Deal Type
-
Alliance
- Includes Contract
- Intra-Biotech Deal
- Marketing (Licensing)
- Product Purchase
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Sequenom acquires patents from Helicos BioSciences
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice